Zkusit zdarma
NovoCure Limited

NovoCure Limited

NVCR
Cena:
$ 18.26
+0.30 (1.67%)
Valuace
70
Růst
15
Zdraví
69
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
International Markets and NovoCure (NVCR): A Deep Dive for Investors

International Markets and NovoCure (NVCR): A Deep Dive for Investors

10:16 04-05-2026

Review NovoCure's (NVCR) international revenue performance and how it affects the predictions of fin...

NovoCure: Pancreatic Launch Looks Promising, But I'm Not A Believer Yet

NovoCure: Pancreatic Launch Looks Promising, But I'm Not A Believer Yet

12:35 01-05-2026

NovoCure Limited has resolved its CMS billing issue, with no material impact on operations or financ...

NovoCure Limited (NVCR) Q1 2026 Earnings Call Transcript

NovoCure Limited (NVCR) Q1 2026 Earnings Call Transcript

14:41 30-04-2026

NovoCure Limited (NVCR) Q1 2026 Earnings Call Transcript...

NovoCure (NVCR) Reports Q1 Loss, Beats Revenue Estimates

NovoCure (NVCR) Reports Q1 Loss, Beats Revenue Estimates

9:35 30-04-2026

NovoCure (NVCR) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimat...

Novocure Reports First Quarter 2026 Financial Results

Novocure Reports First Quarter 2026 Financial Results

7:00 30-04-2026

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today reported financial results for the...

NovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of “Hold” by Analysts

NovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of “Hold” by Analysts

2:30 25-04-2026

Shares of NovoCure Limited (NASDAQ: NVCR - Get Free Report) have received an average rating of "Hold...

Head to Head Contrast: NovoCure (NASDAQ:NVCR) versus Alterity Therapeutics (NASDAQ:ATHE)

Head to Head Contrast: NovoCure (NASDAQ:NVCR) versus Alterity Therapeutics (NASDAQ:ATHE)

1:11 16-04-2026

NovoCure (NASDAQ: NVCR - Get Free Report) and Alterity Therapeutics (NASDAQ: ATHE - Get Free Report)...

JPMorgan Chase & Co. Buys 144,024 Shares of NovoCure Limited $NVCR

JPMorgan Chase & Co. Buys 144,024 Shares of NovoCure Limited $NVCR

4:56 04-04-2026

JPMorgan Chase and Co. lifted its stake in NovoCure Limited (NASDAQ: NVCR) by 104.2% in the undefine...

Novocure to Report First Quarter 2026 Financial Results

Novocure to Report First Quarter 2026 Financial Results

7:00 01-04-2026

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) will report financial results for the fi...

NovoCure Tumor Treating Fields Shows Improved Outcomes In Tough Pancreatic Cancer

NovoCure Tumor Treating Fields Shows Improved Outcomes In Tough Pancreatic Cancer

11:19 26-03-2026

The stock is gaining traction as the company reported a disease control rate of 74.4%, significantly...

Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer

Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer

7:00 26-03-2026

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced positive results today from th...

Novocure's Optune Lua Gets Japan Reimbursement for NSCLC Treatment

Novocure's Optune Lua Gets Japan Reimbursement for NSCLC Treatment

12:56 09-03-2026

NVCR gains Japan NHI reimbursement for Optune Lua in advanced NSCLC, expanding patient access and su...

Tumor Treating Fields (TTFields) Therapy to be Covered for Patients with Newly Diagnosed Glioblastoma Through British Columbia Cancer (BC Cancer)

Tumor Treating Fields (TTFields) Therapy to be Covered for Patients with Newly Diagnosed Glioblastoma Through British Columbia Cancer (BC Cancer)

7:00 24-02-2026

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that the province of Bri...

Will NovoCure (NVCR) Report Negative Earnings Next Week? What You Should Know

Will NovoCure (NVCR) Report Negative Earnings Next Week? What You Should Know

11:00 19-02-2026

NovoCure (NVCR) doesn't possess the right combination of the two key ingredients for a likely earnin...

Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer

Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer

11:05 17-02-2026

NVCR wins early FDA nod for Optune Pax in pancreatic cancer, boosting survival in phase III and open...

NovoCure: FDA Approval For PC Unlocked With TTFields Expansion Opportunity Approaching

NovoCure: FDA Approval For PC Unlocked With TTFields Expansion Opportunity Approaching

17:38 12-02-2026

NovoCure secures FDA approval for Optune Pax in first-line locally advanced pancreatic cancer, the f...

This Biotech Stock Is Jumping 25% After Getting an FDA Boost

This Biotech Stock Is Jumping 25% After Getting an FDA Boost

6:53 12-02-2026

Novocure stock surged after the Food and Drug Administration approved its Optune Pax product, which ...

What's Happening With NovoCure Stock?

What's Happening With NovoCure Stock?

6:15 12-02-2026

NovoCure stock (NVCR) is up over 30% following the FDA's approval of its Optune Pax device for local...

NovoCure (NVCR) Stock Is Trending Overnight — Here's What You Should Know

NovoCure (NVCR) Stock Is Trending Overnight — Here's What You Should Know

21:55 11-02-2026

NovoCure shares surged after FDA approval of Optune Pax for locally advanced pancreatic cancer....

Novocure Gets FDA Approval for Pancreatic Cancer Treatment; Shares Soar

Novocure Gets FDA Approval for Pancreatic Cancer Treatment; Shares Soar

18:33 11-02-2026

The Swiss biopharmaceutical company's shares surged in after-hours trading after it said the FDA app...

close

U.S. FDA APPROVES NOVOCURE'S OPTUNE PAX® FOR THE TREATMENT OF LOCALLY ADVANCED PANCREATIC CANCER

11-02-2026
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) ANNOUNCED TODAY THAT THE U.S. FOOD AND D...
Více zde

NOVOCURE ANNOUNCES PRELIMINARY FULL YEAR AND FOURTH QUARTER 2025 PERFORMANCE AND PROVIDES COMPANY UPDATE

12-01-2026
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) TODAY REPORTED PRELIMINARY UNAUDITED FIN...
Více zde

NOVOCURE TO PRESENT AT 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

22-12-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) ANNOUNCED TODAY THAT MANAGEMENT WILL PAR...
Více zde

NOVOCURE APPOINTS COMPANY PRESIDENT FRANK LEONARD AS CHIEF EXECUTIVE OFFICER

01-12-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)---- $NVCR--NOVOCURE (NASDAQ: NVCR) TODAY ANNOUNCED THE APPOINTMEN...
Více zde

NOVOCURE TO PARTICIPATE IN 37TH ANNUAL PIPER SANDLER HEALTHCARE CONFERENCE

26-11-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) ANNOUNCED TODAY THAT MANAGEMENT WILL PAR...
Více zde

NOVOCURE TO PARTICIPATE IN 2025 JEFFERIES GLOBAL HEALTHCARE CONFERENCE

12-11-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) ANNOUNCED TODAY THAT MANAGEMENT WILL PAR...
Více zde

NOVOCURE REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

30-10-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) TODAY REPORTED FINANCIAL RESULTS FOR THE...
Více zde

NOVOCURE TO PRESENT NEW RESEARCH FOR TUMOR TREATING FIELDS (TTFIELDS) THERAPY AT EUROPEAN ASSOCIATION OF NEURO-ONCOLOGY (EANO) MEETING AND THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) CONGRESS

15-10-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) ANNOUNCED TODAY THAT IT WILL PRESENT DAT...
Více zde

NOVOCURE TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS

01-10-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) WILL REPORT FINANCIAL RESULTS FOR THE TH...
Více zde

NOVOCURE TO PRESENT FINAL RESULTS FROM THE PIVOTAL PHASE 3 METIS TRIAL OF ITS TUMOR TREATING FIELDS (TTFIELDS) THERAPY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER AT 2025 ASTRO ANNUAL MEETING

29-09-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) ANNOUNCED THAT FINAL RESULTS FROM THE PH...
Více zde

NOVOCURE ANNOUNCES UPCOMING INVESTOR EVENTS

28-08-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) ANNOUNCED TODAY THAT MANAGEMENT WILL PAR...
Více zde

NOVOCURE ANNOUNCES COVERAGE OF TUMOR TREATING FIELDS (TTFIELDS) THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA IN SPAIN

25-08-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) ANNOUNCED TODAY THAT SPAIN'S MINISTRY OF...
Více zde

NOVOCURE SUBMITS PREMARKET APPROVAL APPLICATION TO FDA FOR TUMOR TREATING FIELDS THERAPY IN LOCALLY ADVANCED PANCREATIC CANCER

20-08-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) TODAY ANNOUNCED IT SUBMITTED A PREMARKET...
Více zde

NOVOCURE REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

24-07-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) TODAY REPORTED FINANCIAL RESULTS FOR THE...
Více zde

NOVOCURE TO PRESENT FINAL SECONDARY ENDPOINT DATA FROM THE PHASE 3 PANOVA-3 TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) IN PANCREATIC CANCER AT THE ESMO GASTROINTESTINAL CANCERS CONGRESS 2025

01-07-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) ANNOUNCED TODAY THAT IT WILL PRESENT THE...
Více zde

NOVOCURE TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS

30-06-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) WILL REPORT FINANCIAL RESULTS FOR THE SE...
Více zde

ZAI LAB AND NOVOCURE ANNOUNCE RESULTS FROM THE PHASE 3 PANOVA-3 TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) THERAPY FOR PANCREATIC CANCER TO BE PRESENTED AT 2025 ASCO ANNUAL MEETING

31-05-2025
SHANGHAI & CAMBRIDGE, MASS. & BAAR, SWITZERLAND--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKE...
Více zde

RESULTS FROM THE PHASE 3 PANOVA-3 TRIAL OF NOVOCURE'S TUMOR TREATING FIELDS (TTFIELDS) THERAPY FOR PANCREATIC CANCER TO BE PRESENTED AT 2025 ASCO ANNUAL MEETING

31-05-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) ANNOUNCED THAT RESULTS FROM THE PHASE 3 ...
Více zde

NOVOCURE ANNOUNCES UPCOMING INVESTOR EVENTS

27-05-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) ANNOUNCED TODAY THAT MANAGEMENT WILL PAR...
Více zde

NOVOCURE REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

24-04-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) TODAY REPORTED FINANCIAL RESULTS FOR THE...
Více zde

NOVOCURE TO PRESENT RESULTS FROM THE PHASE 3 PANOVA-3 CLINICAL TRIAL OF ITS TUMOR TREATING FIELDS (TTFIELDS) THERAPY FOR PANCREATIC CANCER AS A LATE-BREAKING ORAL PRESENTATION AT THE 2025 ASCO ANNUAL MEETING

23-04-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) ANNOUNCED TODAY THAT IT WILL PRESENT ADD...
Více zde

NOVOCURE'S OPTUNE LUA® RECEIVES CE MARK APPROVAL FOR THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER

22-04-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE (NASDAQ: NVCR) ANNOUNCED TODAY THAT OPTUNE LUA® HAS RE...
Více zde

NOVOCURE INAUGURATES NEW GLOBAL HEADQUARTERS IN CANTON OF ZUG, SWITZERLAND

22-01-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)--NOVOCURE INAUGURATES NEW GLOBAL HEADQUARTERS IN CANTON OF ZUG, S...
Více zde

NOVOCURE ANNOUNCES PRELIMINARY FULL YEAR AND FOURTH QUARTER 2024 PERFORMANCE AND PROVIDES COMPANY UPDATE

13-01-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)---- $NVCR--NOVOCURE ANNOUNCES PRELIMINARY FULL YEAR AND FOURTH QU...
Více zde

NOVOCURE TO PARTICIPATE IN 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

03-01-2025
BAAR, SWITZERLAND--(BUSINESS WIRE)---- $NVCR--NOVOCURE TO PARTICIPATE IN 43RD ANNUAL J.P. MORGAN HEA...
Více zde

ZAI LAB AND NOVOCURE ANNOUNCE POSITIVE TOPLINE RESULTS FROM PHASE 3 PANOVA-3 CLINICAL TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) THERAPY FOR PANCREATIC CANCER

02-12-2024
SHANGHAI & CAMBRIDGE, MASS. & ROOT, SWITZERLAND--(BUSINESS WIRE)--ZAI LAB LIMITED (NASDAQ: ZLAB; HKE...
Více zde

NOVOCURE ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 3 PANOVA-3 CLINICAL TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) THERAPY FOR PANCREATIC CANCER

02-12-2024
ROOT, SWITZERLAND--(BUSINESS WIRE)---- $NVCR--NOVOCURE ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE...
Více zde

NOVOCURE TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

27-11-2024
ROOT, SWITZERLAND--(BUSINESS WIRE)---- $NVCR--NOVOCURE TO PARTICIPATE IN UPCOMING INVESTOR CONFERENC...
Více zde

NOVOCURE DATA AT 2024 SNO ANNUAL MEETING HIGHLIGHTS PRODUCT INNOVATION AND REAL-WORLD EVIDENCE FOR TUMOR TREATING FIELDS (TTFIELDS) THERAPY IN GLIOBLASTOMA

21-11-2024
ROOT, SWITZERLAND--(BUSINESS WIRE)---- $NVCR--NOVOCURE DATA AT 2024 SNO ANNUAL MEETING HIGHLIGHTS PR...
Více zde

FDA APPROVES NOVOCURE'S INNOVATIVE HFE TRANSDUCER ARRAYS FOR USE WITH OPTUNE GIO® FOR GLIOBLASTOMA

21-11-2024
ROOT, SWITZERLAND--(BUSINESS WIRE)---- $NVCR--FDA APPROVES NOVOCURE'S INNOVATIVE HFE TRANSDUCER ARRA...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-11 00:00:008-KStáhnout
2026-02-05 00:00:008-KStáhnout
2026-01-12 00:00:008-KStáhnout
2025-12-01 00:00:008-KStáhnout
2025-10-30 00:00:008-KStáhnout
2025-10-30 00:00:0010-QStáhnout
2025-09-15 01:00:008-KStáhnout
2025-09-15 00:00:008-KStáhnout
2025-08-28 01:00:008-KStáhnout
2025-08-28 00:00:008-KStáhnout
2025-07-24 01:00:008-KStáhnout
2025-07-24 01:00:0010-QStáhnout
2025-07-24 00:00:008-KStáhnout
2025-07-24 00:00:0010-QStáhnout
2025-06-06 01:00:008-KStáhnout
2025-06-06 00:00:008-KStáhnout
2025-06-02 01:00:008-KStáhnout
2025-06-02 00:00:008-KStáhnout
2025-04-24 01:00:008-KStáhnout
2025-04-24 01:00:0010-QStáhnout
2025-04-24 00:00:008-KStáhnout
2025-04-24 00:00:0010-QStáhnout
2025-04-22 01:00:008-KStáhnout
2025-04-22 00:00:008-KStáhnout
2025-02-27 00:00:008-KStáhnout
2025-02-27 00:00:0010-KStáhnout
2025-02-26 23:00:008-KStáhnout
2025-02-26 23:00:0010-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-12-02 00:00:008-KStáhnout
2024-12-01 23:00:008-KStáhnout
2024-10-30 00:00:008-KStáhnout
2024-10-30 00:00:0010-QStáhnout
2024-10-29 23:00:008-KStáhnout
2024-10-29 23:00:0010-QStáhnout
2024-10-15 01:00:008-KStáhnout
2024-10-15 00:00:008-KStáhnout
2024-09-03 01:00:008-KStáhnout
2024-09-03 00:00:008-KStáhnout
2024-07-25 01:00:008-KStáhnout
2024-07-25 01:00:0010-QStáhnout
2024-07-25 00:00:008-KStáhnout
2024-07-25 00:00:0010-QStáhnout
2024-06-10 01:00:008-KStáhnout
2024-06-10 00:00:008-KStáhnout
2024-05-20 01:00:008-KStáhnout
2024-05-20 00:00:008-KStáhnout
2024-05-02 01:00:008-KStáhnout
2024-05-02 01:00:0010-QStáhnout
2024-05-02 00:00:008-KStáhnout
2024-05-02 00:00:0010-QStáhnout
2024-03-27 00:00:008-KStáhnout
2024-03-26 23:00:008-KStáhnout
2024-02-22 00:00:008-KStáhnout
2024-02-22 00:00:0010-KStáhnout
2024-02-21 23:00:008-KStáhnout
2024-02-21 23:00:0010-KStáhnout
2024-01-18 00:00:008-KStáhnout
2024-01-17 23:00:008-KStáhnout
2024-01-09 00:00:008-KStáhnout
2024-01-08 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2024-01-04 00:00:008-KStáhnout
2024-01-03 23:00:008-KStáhnout
2023-11-28 00:00:008-KStáhnout
2023-11-27 23:00:008-KStáhnout
2023-10-26 01:00:008-KStáhnout
2023-10-26 01:00:0010-QStáhnout
2023-10-26 00:00:008-KStáhnout
2023-10-26 00:00:0010-QStáhnout
2023-08-28 01:00:008-KStáhnout
2023-08-28 00:00:008-KStáhnout
2023-07-27 01:00:008-KStáhnout
2023-07-27 01:00:0010-QStáhnout
2023-07-27 00:00:008-KStáhnout
2023-07-27 00:00:0010-QStáhnout
2023-07-21 01:00:008-KStáhnout
2023-07-21 00:00:008-KStáhnout
2023-06-08 01:00:008-KStáhnout
2023-06-08 00:00:008-KStáhnout
2023-06-06 01:00:008-KStáhnout
2023-06-06 00:00:008-KStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 01:00:0010-QStáhnout
2023-05-04 00:00:008-KStáhnout
2023-05-04 00:00:0010-QStáhnout
2023-04-26 01:00:008-KStáhnout
2023-04-26 00:00:008-KStáhnout
2023-03-29 01:00:008-KStáhnout
2023-03-29 00:00:008-KStáhnout
2023-02-23 00:00:008-KStáhnout
2023-02-23 00:00:0010-KStáhnout
2023-02-22 23:00:008-KStáhnout
2023-02-22 23:00:0010-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2023-01-05 00:00:008-KStáhnout
2023-01-04 23:00:008-KStáhnout
2022-11-04 00:00:008-KStáhnout
2022-11-03 23:00:008-KStáhnout
2022-10-27 01:00:008-KStáhnout
2022-10-27 01:00:0010-QStáhnout
2022-10-27 00:00:008-KStáhnout
2022-10-27 00:00:0010-QStáhnout
2022-07-28 01:00:008-KStáhnout
2022-07-28 01:00:0010-QStáhnout
2022-07-28 00:00:008-KStáhnout
2022-07-28 00:00:0010-QStáhnout
2022-06-10 01:00:008-KStáhnout
2022-06-10 00:00:008-KStáhnout
2022-06-03 01:00:008-KStáhnout
2022-06-03 00:00:008-KStáhnout
2022-05-26 01:00:008-KStáhnout
2022-05-26 00:00:008-KStáhnout
2022-04-28 01:00:008-KStáhnout
2022-04-28 01:00:0010-QStáhnout
2022-04-28 00:00:008-KStáhnout
2022-04-28 00:00:0010-QStáhnout
2022-04-13 01:00:008-KStáhnout
2022-04-13 00:00:008-KStáhnout
2022-04-07 01:00:008-KStáhnout
2022-04-07 00:00:008-KStáhnout
2022-03-23 00:00:008-KStáhnout
2022-03-22 23:00:008-KStáhnout
2022-02-24 00:00:008-KStáhnout
2022-02-24 00:00:0010-KStáhnout
2022-02-23 23:00:008-KStáhnout
2022-02-23 23:00:0010-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2021-12-30 00:00:008-KStáhnout
2021-12-29 23:00:008-KStáhnout
2021-12-07 00:00:008-KStáhnout
2021-12-06 23:00:008-KStáhnout
2021-10-28 01:00:008-KStáhnout
2021-10-28 01:00:0010-QStáhnout
2021-10-28 00:00:008-KStáhnout
2021-10-28 00:00:0010-QStáhnout
2021-07-29 01:00:008-KStáhnout
2021-07-29 01:00:0010-QStáhnout
2021-07-29 00:00:008-KStáhnout
2021-07-29 00:00:0010-QStáhnout
2021-06-11 01:00:008-KStáhnout
2021-06-11 00:00:008-KStáhnout
2021-04-29 01:00:008-KStáhnout
2021-04-29 01:00:0010-QStáhnout
2021-04-29 00:00:008-KStáhnout
2021-04-29 00:00:0010-QStáhnout
2021-04-13 01:00:008-KStáhnout
2021-04-13 00:00:008-KStáhnout
2021-02-25 00:00:008-KStáhnout
2021-02-25 00:00:0010-KStáhnout
2021-02-24 23:00:008-KStáhnout
2021-02-24 23:00:0010-KStáhnout
2021-02-08 00:00:008-KStáhnout
2021-02-07 23:00:008-KStáhnout
2021-02-01 00:00:008-KStáhnout
2021-01-31 23:00:008-KStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2020-11-09 00:00:008-KStáhnout
2020-11-08 23:00:008-KStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-04 23:00:008-KStáhnout
2020-11-03 00:00:008-KStáhnout
2020-11-02 23:00:008-KStáhnout
2020-10-29 00:00:008-KStáhnout
2020-10-29 00:00:0010-QStáhnout
2020-10-28 23:00:008-KStáhnout
2020-10-28 23:00:0010-QStáhnout
2020-08-13 01:00:008-KStáhnout
2020-08-13 00:00:008-KStáhnout
2020-08-06 01:00:008-KStáhnout
2020-08-06 00:00:008-KStáhnout
2020-07-30 01:00:008-KStáhnout
2020-07-30 01:00:0010-QStáhnout
2020-07-30 00:00:008-KStáhnout
2020-07-30 00:00:0010-QStáhnout
2020-07-15 01:00:008-KStáhnout
2020-07-15 00:00:008-KStáhnout
2020-06-12 01:00:008-KStáhnout
2020-06-12 00:00:008-KStáhnout
2020-05-13 01:00:008-KStáhnout
2020-05-13 00:00:008-KStáhnout
2020-04-30 01:00:008-KStáhnout
2020-04-30 01:00:0010-QStáhnout
2020-04-30 00:00:008-KStáhnout
2020-04-30 00:00:0010-QStáhnout
2020-04-24 01:00:008-KStáhnout
2020-04-24 00:00:008-KStáhnout
2020-03-06 00:00:008-KStáhnout
2020-03-05 23:00:008-KStáhnout
2020-02-27 00:00:008-KStáhnout
2020-02-27 00:00:0010-KStáhnout
2020-02-26 23:00:008-KStáhnout
2020-02-26 23:00:0010-KStáhnout
2020-01-13 00:00:008-KStáhnout
2020-01-12 23:00:008-KStáhnout
2019-10-31 00:00:008-KStáhnout
2019-10-31 00:00:0010-QStáhnout
2019-10-30 23:00:008-KStáhnout
2019-10-30 23:00:0010-QStáhnout
2019-07-25 01:00:008-KStáhnout
2019-07-25 01:00:0010-QStáhnout
2019-07-25 00:00:008-KStáhnout
2019-07-25 00:00:0010-QStáhnout
2019-07-19 01:00:008-KStáhnout
2019-07-19 00:00:008-KStáhnout
2019-07-18 01:00:008-KStáhnout
2019-07-18 00:00:008-KStáhnout
2019-05-24 01:00:008-KStáhnout
2019-05-24 00:00:008-KStáhnout
2019-05-22 01:00:008-KStáhnout
2019-05-22 00:00:008-KStáhnout
2019-05-02 01:00:008-KStáhnout
2019-05-02 01:00:0010-QStáhnout
2019-05-02 00:00:008-KStáhnout
2019-05-02 00:00:0010-QStáhnout
2019-04-05 01:00:008-KStáhnout
2019-04-05 00:00:008-KStáhnout
2019-03-21 00:00:008-KStáhnout
2019-03-20 23:00:008-KStáhnout
2019-02-28 00:00:008-KStáhnout
2019-02-28 00:00:0010-KStáhnout
2019-02-27 23:00:008-KStáhnout
2019-02-27 23:00:0010-KStáhnout
2019-01-07 00:00:008-KStáhnout
2019-01-06 23:00:008-KStáhnout
2018-10-25 01:00:008-KStáhnout
2018-10-25 01:00:0010-QStáhnout
2018-10-25 00:00:008-KStáhnout
2018-10-25 00:00:0010-QStáhnout
2018-09-12 01:00:008-KStáhnout
2018-09-12 00:00:008-KStáhnout
2018-09-06 01:00:008-KStáhnout
2018-09-06 00:00:008-KStáhnout
2018-07-31 01:00:008-KStáhnout
2018-07-31 00:00:008-KStáhnout
2018-07-26 01:00:008-KStáhnout
2018-07-26 01:00:0010-QStáhnout
2018-07-26 00:00:008-KStáhnout
2018-07-26 00:00:0010-QStáhnout
2018-07-06 01:00:008-KStáhnout
2018-07-06 00:00:008-KStáhnout
2018-06-06 01:00:008-KStáhnout
2018-06-06 00:00:008-KStáhnout
2018-04-26 01:00:008-KStáhnout
2018-04-26 01:00:0010-QStáhnout
2018-04-26 00:00:008-KStáhnout
2018-04-26 00:00:0010-QStáhnout
2018-04-17 01:00:008-KStáhnout
2018-04-17 00:00:008-KStáhnout
2018-04-09 01:00:008-KStáhnout
2018-04-09 00:00:008-KStáhnout
2018-04-04 01:00:008-KStáhnout
2018-04-04 00:00:008-KStáhnout
2018-02-22 00:00:008-KStáhnout
2018-02-22 00:00:0010-KStáhnout
2018-02-21 23:00:008-KStáhnout
2018-02-21 23:00:0010-KStáhnout
2018-02-08 00:00:008-KStáhnout
2018-02-07 23:00:008-KStáhnout
2018-01-09 00:00:008-KStáhnout
2018-01-08 23:00:008-KStáhnout
2017-12-06 00:00:008-KStáhnout
2017-12-05 23:00:008-KStáhnout
2017-10-26 01:00:008-KStáhnout
2017-10-26 01:00:0010-QStáhnout
2017-10-26 00:00:008-KStáhnout
2017-10-26 00:00:0010-QStáhnout
2017-10-05 01:00:008-KStáhnout
2017-10-05 00:00:008-KStáhnout
2017-08-01 01:00:008-KStáhnout
2017-08-01 00:00:008-KStáhnout
2017-07-27 01:00:008-KStáhnout
2017-07-27 01:00:0010-QStáhnout
2017-07-27 00:00:008-KStáhnout
2017-07-27 00:00:0010-QStáhnout
2017-05-12 01:00:008-KStáhnout
2017-05-12 00:00:008-KStáhnout
2017-04-27 01:00:008-KStáhnout
2017-04-27 01:00:0010-QStáhnout
2017-04-27 00:00:008-KStáhnout
2017-04-27 00:00:0010-QStáhnout
2017-03-31 01:00:008-KStáhnout
2017-03-31 00:00:008-KStáhnout
2017-03-27 01:00:008-KStáhnout
2017-03-27 00:00:008-KStáhnout
2017-02-23 00:00:008-KStáhnout
2017-02-23 00:00:0010-KStáhnout
2017-02-22 23:00:008-KStáhnout
2017-02-22 23:00:0010-KStáhnout
2016-12-30 00:00:008-KStáhnout
2016-12-29 23:00:008-KStáhnout
2016-11-02 00:00:008-KStáhnout
2016-11-02 00:00:0010-QStáhnout
2016-11-01 23:00:008-KStáhnout
2016-11-01 23:00:0010-QStáhnout
2016-10-14 01:00:008-KStáhnout
2016-10-14 00:00:008-KStáhnout
2016-09-07 01:00:008-KStáhnout
2016-09-07 00:00:008-KStáhnout
2016-08-15 01:00:008-KStáhnout
2016-08-15 00:00:008-KStáhnout
2016-07-28 01:00:008-KStáhnout
2016-07-28 01:00:0010-QStáhnout
2016-07-28 00:00:008-KStáhnout
2016-07-28 00:00:0010-QStáhnout
2016-07-19 01:00:008-KStáhnout
2016-07-19 00:00:008-KStáhnout
2016-06-30 01:00:008-KStáhnout
2016-06-30 00:00:008-KStáhnout
2016-05-25 01:00:008-KStáhnout
2016-05-25 00:00:008-KStáhnout
2016-05-13 01:00:008-KStáhnout
2016-05-13 00:00:008-KStáhnout
2016-05-10 01:00:0010-QStáhnout
2016-05-10 00:00:0010-QStáhnout
2016-05-09 01:00:008-KStáhnout
2016-05-09 00:00:008-KStáhnout
2016-05-06 01:00:008-KStáhnout
2016-05-06 00:00:008-KStáhnout
2016-03-29 01:00:008-KStáhnout
2016-03-29 00:00:008-KStáhnout
2016-03-22 00:00:008-KStáhnout
2016-03-21 23:00:008-KStáhnout
2016-03-01 00:00:0010-KStáhnout
2016-02-29 23:00:0010-KStáhnout
2016-02-29 00:00:008-KStáhnout
2016-02-28 23:00:008-KStáhnout
2016-01-11 00:00:008-KStáhnout
2016-01-10 23:00:008-KStáhnout
2015-12-22 00:00:008-KStáhnout
2015-12-21 23:00:008-KStáhnout
2015-12-15 00:00:008-KStáhnout
2015-12-14 23:00:008-KStáhnout
2015-12-03 00:00:008-KStáhnout
2015-12-02 23:00:008-KStáhnout
2015-12-02 00:00:008-KStáhnout
2015-12-01 23:00:008-KStáhnout
2015-11-20 00:00:008-KStáhnout
2015-11-19 23:00:008-KStáhnout
2015-10-27 00:00:0010-QStáhnout
2015-10-26 23:00:0010-QStáhnout
2015-10-26 00:00:008-KStáhnout
2015-10-25 23:00:008-KStáhnout
2015-10-19 01:00:008-KStáhnout
2015-10-19 00:00:008-KStáhnout
2015-10-08 01:00:008-KStáhnout
2015-10-08 00:00:008-KStáhnout
preloader